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In this contribution, we describe a multi-omics systems biology study of the metabolic
changes that occur during aging inCaenorhabditis elegans. Sampling several time points
from young adulthood until early old age, our study covers the full duration of aging and
include transcriptomics, and targeted MS-based metabolomics. In order to focus on
the metabolic changes due to age we used two strains that are metabolically close to
wild-type, yet are conditionally non-reproductive. Using these data in combination with a
whole-genome model of the metabolism of C. elegans and mathematical modeling, we
predictedmetabolic fluxes during early aging.We find that standard Flux Balance Analysis
does not accurately predict in vivo measured fluxes nor age-related changes associated
with the Citric Acid cycle. We present a novel Flux Balance Analysis method where we
combined biomass production and targeted metabolomics information to generate an
objective function that is more suitable for aging studies. We validated this approach
with a detailed case study of the age-associated changes in the Citric Acid cycle. Our
approach provides a comprehensive time-resolved multi-omics and modeling resource
for studying the metabolic changes during normal aging in C. elegans.
Keywords: metabolomics, flux balance analysis, aging, systems biology, multi-omics, whole genome model, C.
elegans
INTRODUCTION
The nematode C. elegans is widely used as a model organism to interrogate the molecular
mechanisms of aging (Guarente and Kenyon, 2000). Many genes and interventions that
prolong life, collectively called longevity pathways, are conserved across species, and cause
global remodeling of metabolic pathways (López-Otín et al., 2016). To fully understand what
makes a certain type of metabolism healthy, it is crucial to understand how it compares
to metabolic changes that occur during the normal course of aging. Morphological changes
evident in post-reproductive wild-type C. elegans point toward the loss of key metabolic
capabilities during normal aging. For example, the intestine, which is the main metabolic
organ in worms, undergoes atrophy with age (Ezcurra et al., 2018). Another key metabolic
change is that mitochondria become fragmented and lose volume (Yasuda et al., 2006;
Regmi et al., 2014) with a concurrent loss of electron chain oxygen consumption and
ATP production (Braeckman et al., 2002; Houthoofd et al., 2005). Mitochondrial damage
is also a hallmark of human aging (Chaudhari and Kipreos, 2018) and can be delayed
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using interventions that prolong life (Houthoofd et al., 2005; Brys
et al., 2010). Various age-related pathologies can be observed in
worms after the time of sperm depletion and are fully evident
prior to median lifespan (Ezcurra et al., 2018). Consistently
with these observations, functional assays have identified several
metabolites that are able to delay aging in worms, e.g.,
oxaloacetate (Williams et al., 2009), alpha-ketoglutarate (Chin
et al., 2014), and N-acylethanolamine (Lucanic et al., 2011).
Omics techniques can provide a global overview and aid
in the elucidation of the causes underlying early decay. For
example, metabolic changes that characterize wild type and
long-lived C. elegans strains have been previously studied by
metabolomics alone (Fuchs et al., 2010; Pontoizeau et al., 2014)
as well as multi-omics approaches including metabolomics as
one layer (Copes et al., 2015; Davies et al., 2015; Gao et al.,
2017a,b; Wan et al., 2017). However, one common problem
with omics applied to aging samples is that C. elegans is a
hermaphroditic species and contamination of aging populations
with progeny introduces a confounder. The use of 5′-fluoro-2′-
deoxyuridine (FUDR) can circumvent this problem because it
decreases progeny production by reducing germ cell division,
however this treatment has been shown to directly influence
metabolism (Davies et al., 2012; García-González et al., 2017;
Scott et al., 2017). As a consequence, the early stages of the
aging process are either under-sampled or have been subjected
to a chemical intervention, clouding our view of the normal
aging process. It is key to circumvent these technical problems
because a better understanding of the mechanisms that explain
early age-related decline can potentially lead to the development
of interventions targeting the delay of aging and prevention of
age-associated disease in humans.
Recent advances in modeling approaches enable the use of
-omics datasets in conjunction with genome-scale metabolic
models (GSMM) for in silico predictive studies. GSMMs are
mathematical representations of all known metabolic reactions
in an organism. Three such models have been recently published
for C. elegans (Gebauer et al., 2016; Yilmaz and Walhout, 2016;
Ma et al., 2017) and a community-driven approach has reconciled
and extended these into a consensus model (Hastings et al.,
2017; Witting et al., 2018). Whole-genome metabolic models
can be used to predict intracellular turnover rates (fluxes) for
metabolic reactions using for instance Flux Balance Analysis
(FBA), a mathematical method that uses the stoichiometry of
every reaction in a whole system to derive a steady state solution
by optimizing an objective function, usually growth (Orth et al.,
2010). To reduce the space of possible solutions, it is necessary to
add constraints based on experimental data. Enzyme expression
levels, provided by proteomics or transcriptomics data, are
usually used as a proxy for the expected flux through any
reaction catalyzed by that enzyme. Because FBA calculates the
flow of metabolites throughout the global network, it allows the
elucidation of how changes in one component of the model affect
other pathways and phenotypes (such as growth rate or the rate of
production of a certain metabolite), and in this way it can provide
valuable mechanistic insights (Orth et al., 2010).
In this study we have used two infertile but normal-lived
strains grown in the absence of FUDR, to conduct temporally
resolved multi-omics studies, including transcriptomics, and
targeted MS-based metabolomics. We characterize the changes
over the course of aging in about 100 metabolites to find 44 that
change significantly with age. Among these, more than half of
them have already been characterized as longevity modulators.
The data shows metabolic shifts during the course of aging,
with a prominent decrease in the levels of aminoacids while
their polyamine derivatives increase. In addition, metabolites
involved in the TCA cycle become imbalanced before worms
reach middle age. We harnessed this data using FBA during
the course of normal aging before midlife. When looking
at central carbon metabolism, we noticed that the model
constrained by transcriptomics was unable to accurately match
previous in vivo measured fluxes. While ordinarily, the objective
function for FBA is linked to growth, for aging post-mitotic
multicellular organisms, growth can no longer be assumed to be
the appropriate objective. Thus, we create an objective function
that qualitatively incorporates in vivo measured metabolomics
information by instructing the model that if a metabolite level
changes significantly between two time points, the associated
reactions should either produce or consume that metabolite.
We find that when using the TCA cycle as a case study, the
usage of multi-omics data with FBA provides more accurate
predictions than standard FBA, indicating that the new objective
function is better suited for FBA studies in post-developmental
worms. This optimized method correctly predicts that the most
decreased fluxes within the TCA metabolic shift are through
oxaloacetate, in line with experiments that show that it becomes
the most limiting TCA-related metabolite in old animals. The
model also provides a mechanistic explanation that links the
decreased production of glutamate to a malfunctioning TCA
cycle. In summary, we present a valuable multi-omics resource
that can be used as a baseline for other early aging studies as
well as an improved systems biology tool that provides a closer
representation to the in vivometabolism of normal lived animals.
MATERIALS AND METHODS
Additional methods can be found in Supplementary Material.
Strains
List of strains used in this study:
GR1395 mgIs49[mlt-10p::GFP-pest; ttx-1p::GFP] IV
MOC001 GR1395 outcrossed to N2, 7 times
EJ1171 gon-2(q388); gem-1(bc364)
JK816 fem-3(q20) IV
MOC91 gon-2(q388); gem-1(bc364); mgIs49[mlt-10p::GFP-
pest; ttx-1p::GFP] IV
GR1395 was obtained from A. Frand’s lab (Frand et al., 2005).
The mlt-10p::GFP molting reporter was used to identify the
exact molting times and ensure developmental timing did not
differ between strains. EJ1171 was a kind gift from Eric Lambie’s
lab (Kemp et al., 2009); stocks were grown at 16◦C in Mg2+
containing plates and thawed regularly. Before using them for
experiments they were passed for 2 generations at 16◦C in
regular media without Mg2+. Conditional sterility was obtained
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by growing L1 larvae to adulthood at restrictive temperature
(25◦C). At 25◦C the penetrance of gonadogenesis failure in gon-
2(q388); gem-1(bc364) is <100%, whereas for fem-3(q20) the
penetrance is complete.
Worm Maintenance and Sample
Information
Worms were maintained at 16◦C on NGM with OP50 E.
coli. Synchronized experimental populations were prepared by
washing gravid adults and eggs from plates and bleaching in a
freshly prepared solution of 1% sodium hypochlorite and 1M
potassium hydroxide. Eggs were allowed to hatch overnight at
25◦C in M9 solution (22mMKH2P04; 42mMNa2HP04; 86mM
NacL; 1mM MgSo4) to ensure all animals arrested at the L1
stage. This produced a tightly synchronized population which
was confirmed by mlt-10p::GFP fluorescence. Experimental
populations were placed at 25◦C on HT115 E. coli containing the
empty vector plasmid L4440 on standard NGM plates containing
50µg/ml Carbenicillin, 1mM IPTG, and 10µg/ml Nystatin until
harvesting. For the gon-2(q388); gem-1(bc364); strain, samples
were inspected before harvesting and visibly fertile worms were
picked off. Plates with large numbers of visibly fertile worms
were discarded. (Note that under highmagnification a degenerate
gonad could be seen in a subset of gon-2(q388); gem-1(bc364);
animals at 117 h (D4) and were not discarded). Samples were
harvested at the following hours post-feeding of arrested L1:
• Day 1: Hours 41 and 49 post feeding (3 replicates per strain per
time point)
• Day 2: Hours 65 and 73 post feeding (3 replicates per strain per
time point)
• Day 3: Hours 89 and 97 post feeding (3 replicates per strain per
time point)
• Day 4: 117 h post feeding (3 replicates per strain)
• Day 5: 137 h post feeding (2 replicates per strain)
• Day 10: 257 h post feeding (2 replicates per strain).
RNA-Sequencing
Samples of at least 1,000 worms were prepared as described
in Supplementary Methods “RNA-Sequencing Library
Preparation.” For PCR library enrichment, 13 cycles of
amplification were performed. Library quality was assessed
on a Bioanalyzer High Sensitivity DNA Chip (Agilent 5,067–
4,626) and concentration was determined using KAPA Library
Quantification Kit (KK4824). Libraries were sequenced on an
Illumina HiSeq 2,500 system by the Babraham Sequencing
Facility.
RNA-Seq Data Analysis
RNA-Sequencing data was prepared and normalized as described
in Supplementary Methods “RNA-Seq data preparation and
normalization” and Figure S1. Briefly, raw reads were trimmed
and mapped to the C. elegans WBCel235 genome assembly
using HISAT2 (Liu et al., 2017). All libraries were mapped
as non-directional single-end. Only exactly overlapping reads
were assigned to a gene and transcript-isoforms were merged.
Raw counts were generated using Seqmonk (Babraham
Bioinformatics, http://www.bioinformatics.babraham.ac.uk/
projects/seqmonk/) and all subsequent analysis was performed
in R (http://www.R-project.org). The DESeq2 package (Love
et al., 2014) was used to generate normalized counts.
Metabolomics Assay
Targeted metabolomics using Mass Spectrometry was performed
by the Northwestern Metabolomics Research Center (https://
depts.washington.edu/mmcslu/resources/current-research/
metabolomics/) from a batch containing ∼2,000 worms per
replicate. Worms were washed several times with M9 and
snap frozen in water. Samples were homogenized with a bullet
blender in 0.1x PBS at 4◦C, protein precipitated with methanol,
sonication, and centrifugation. The supernatant was removed
and dried in a vacufuge (Speedvac) at 30◦C. All samples were
processed in parallel to avoid batch effects.
Targeted LC-MS/MS metabolomics targeting a list of 210
metabolites was performed on a system consisting of Shimadzu
Nexera XR LC-20AD pumps coupled to a Sciex 6,500+ triple
quadrupole spectrometer operating in MRM detection mode
through the Sciex Analyst 1.6.3 software. The system includes a
dual column setup with dedicated columns for positive ionization
mode and negative ionization mode. The results for each
sample are therefore the result of two injections. Metabolite
concentrations were quantified using Multiquant 3.0 software
in relative manner. The samples were separated on a Waters
Xbridge BEH amide column (2.5 um, 130 angstroms, 2.1 x
150mm) operated in a HILIC regime at 40C. Solvent A consisted
of 95% water, 3% acetonitrile, 2% methanol, 0.2% Acetic
Acid (v/v/v/v) 10mM ammonium acetate, pH ∼4.2. Solvent B
consisted of 93% acetonitrile, 5% water, 2%methanol, 0.2% acetic
acid, and 10mM ammonium acetate. Organic solvents and acetic
acid were Optima grade from Fisher Scientific USA, ammonium
acetate was from Sigma Aldrich. 18.2 MOhm water was from a
Synergy UV system by Millipore. Gradient at 0.300 mL/min was
as follows: 0–3min 95% B, 3–8min 95–50% B, 8–12min 50% B,
12–13min 50–95% B 13–18.1min 95% B. During the injection
on columns of opposite polarity solvent continued at 95% B
giving each column∼23min of equilibration time. Samples were
normalized to total protein content quantified by Bradford assay.
Metabolomics Data Analysis
Metabolomics data analysis was performed using R (http://www.
R-project.org). As is typical in this type of metabolomics data,
there were several missing values in the dataset. We removed
metabolites that had more than 10% such missing values across
all samples, leaving 105 metabolites. For the remainder of the
missing values, we interpolated them by replacing missing values
with the row (metabolite) mean (across all samples) so as not
to affect downstream analyses. This is a standard practice in
metabolomics analyses. The dataset was then transformed using
the inverse hyperbolic sine, which is linear for small x while
asymptotically approaching log(2x). In particular, zero values
are mapped to zero and all other values are mapped to positive
values (which is not true for log-transformation). The data were
further normalized by mean-centering and scaling so that every
metabolite had a mean of 0 and a standard deviation of 1,
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rendering the values comparable. The normalized dataset can
be found in Supplementary Table 4. Initial investigation of the
dataset indicated that one sample was an outlier needing to be
removed as it was separated from the remainder of the dataset in
the unsupervised PCA, and moreover had a high within-sample
coefficient of variation.
Analysis of Variability Drivers–PCA,
Distances, Correlations
Principal component analysis (PCA) was conducted for both
the transcriptomics and the metabolomics datasets using the
“prcomp” package in R and the samples were visualized as
distributed in the first two principal components. Sample to
sample correlations were calculated and plotted using the
“corrplot” package in R. Sample to sample distances were
calculated using 1-cor(x,y) for each pair of samples x and y.
The density plot of sample to sample distances was plotted by
categorizing the pairs (x,y) of samples according to whether they
were replicates or had the same age (but different strains) or had
the same strain (but different ages).
Data Availability
The RNA-Sequencing dataset is available from the Gene
Expression Omnibus (GEO) database with accession
GSE124994 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgiacc=GSE124994). The metabolomics dataset is available as a
Supplementary File (see Supplementary Materials for details).
Determination of Age-Associated
Metabolites
To determine which metabolites were significantly changing
with age in our metabolomics dataset, partial least squares
discriminant analysis (PLS-DA), as implemented in the R
package “ropls” (Thévenot et al., 2015), was used with normalized
metabolite abundances, with the sample time in hours as the
variable. PLS-DA is a latent variable regression method based
on covariance between the predictors and the response, has
been shown to efficiently handle datasets with multi-collinear
predictors, as in the case of spectrometry measurements (Wold
et al., 2001). PLS-DA is a linear regression-based method, thus
non-linear effects with respect to aging will be overlooked. The
Variable Importance in Projection (VIP), reflects both the loading
weights for each component and the variability of the response
explained by this component and can be used for feature selection
(Pinto et al., 2012). The heat map of age-associated metabolites
was plotted using the R function “heatmap.2.”
Flux Balance Analysis (FBA) Pipeline
We used the WormJam C. elegans whole-genome metabolic
reconstruction, version dated 25-01-2018. This model
includes 3,301 reactions and 2,393 metabolites (1,334 unique
metabolites after discarding duplication of metabolites across
compartments). The CobraPy library in Python (Ebrahim
et al., 2013) was used to run FBA and as a basis for the
implementation of FBA-associated methods, including
integration of transcriptomics and metabolomics data. All
sources of input (uptake) were constrained to zero except oxygen
(maximum of 100 units allowed uptake), bacterial input as food
source (maximum of 10 units allowed uptake) and trace minerals
and ions (Ca2+, Cu2+, K+, Mg2+, Mn2+, Na+, Zn2+; arbitrary
allowed uptake). The biomass reaction used as the default
objective function included glycans, phospholipids, collagens,
DNA, RNA, free fatty acids, glycogens, proteins, triacylglycerols,
and trehalose. FBAwas executed using COBRApy’s parsimonious
FBA method “cobra.flux_analysis.pfba.”
Integration of Transcriptomics Data With
FBA
The transcriptomics data were first log-transformed and then
means were obtained for biological replicates in order to have
a single expression value per time point and strain. These
were integrated with the model using a two-step approach.
First, a context-specific model was built by removing reactions
mediated by genes whose expression was below a threshold
(Akesson et al., 2004). Then for the remaining reactions, the E-
flux approach (Colijn et al., 2009) was used, in which reaction
upper (and lower if the reaction is reversible) bounds are set in
proportion to the expression level. Where multiple genes were
annotated to a reaction using OR-logic (i.e., any of the genes
may catalyze the same reaction), their expression levels were
added together to obtain the reaction constraint. For complexes,
where multiple genes are annotated to the reaction using AND-
logic (i.e., all of the genes are needed to catalyze the reaction),
the minimum of their expression levels was used to obtain the
reaction constraint. In total, 2,178 reactions in the model were
constrained by transcriptomics information. The bulk of the
remaining reactions had no annotated genes; only seven reactions
had genes annotated that were absent in the transcriptomics
dataset.
Integration of Metabolomics Data With FBA
There is no direct correspondence between metabolite levels and
fluxes in FBA. Previous approaches to integrate metabolomics
data with FBA include: (1) requiring that detected metabolites
are produced in non-zero quantities by the model (e.g., GIM3E,
Schmidt et al., 2013), (2) calculating a rate of change for a
metabolite from a time series or between two time points, and
requiring the production of the metabolite by the model to
correspond to the rate of change [e.g., TREM-flux, Kleessen
et al., 2015, and (3) “unsteady state” FBA, Bordbar et al., 2017].
Our approach is similar to those mentioned in (2) in that we
require a time series of metabolomics measurements, but in
contrast to those approaches we do not use the metabolomics
values to constrain the model, but rather to alter the objective.
We chose this approach because our first experiments using
FBA on this dataset showed that using a constraints-based
metabolomics data integration approach would lead to the model
not being able to grow at some of our time points, as incompatible
constraints are generated (Figure S9B). While ordinarily, the
objective function for FBA is linked to growth, for multicellular
organisms, growth can no longer be assumed to be the sole
cellular objective and other phenotypically appropriate proxies
are needed. We consider that, from a cellular perspective, if a
metabolite level has increased between two time points, then this
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implies that within that timeframe the sum of fluxes through all
reactions producing that metabolite (i.e., its supply) must have
exceeded the sum of the fluxes through all reactions consuming
it (i.e., its demand). Conversely, if the metabolite level decreased,
then within that timeframe, the demand must have exceeded
the supply (further described in the text and in Figure 6).
Accordingly, we added the net-production or net-consumption
of changed metabolites as an additional objective function
alongside the production of biomass, simultaneously maximizing
biomass and production or consumption of the relevant
metabolites.
Our method can be formulated mathematically as follows:
∀i ∈ (2 ≤ i ≤ N),
maximise
(
cTv + uTv− dTv
)
s.t.
Sv = 0 ,
trL ≤ v ≤ trU
uT =
{





∀m ∈ M, 1 if xmi < xmi−1 , else 0
}
where N is the total number of time points, i is the index
of a particular time point, cT is the vector of coefficients
of the biomass equation, uT is the vector of coefficients for
demand reactions corresponding to the metabolites with level
increases between time points i and i-1, dT is the vector
of coefficients for demand reactions corresponding to the
metabolites with level decreases between time points i and i-1,
S is the stoichiometric matrix for all reactions in the model, v
is the vector of fluxes, M is the set of all measured metabolites
that could be mapped to the model, xmi is a metabolite level
for a particular metabolite m at a given time point i, and trL,
and trU are flux lower and upper constraints set from the
transcriptomics data using the method described in the previous
section.
For each metabolite, a t-test was used to determine which
metabolite levels had changed significantly between consecutive
time points. For two of the total number of time points per strain,
we had only two replicates, insufficient for a statistical test of
this type, thus the strains were combined to give at least four
data points per time point. This was justified by our finding that
strain differences are not the main driver of variability in the
measured metabolome. A comparison of the means was then
used to determine if the metabolites with level changes had
increased or decreased. We were only able to do this for (N-1)
of the N time points; flux predictions at the initial time point
are thus unaffected by the metabolomics data. Moreover, there
were no significant metabolite level changes between time points
89 and 97 h (day 3). Only metabolites which could be mapped
to model metabolites were included: this was the case for 75 of
the 105 measured metabolites. Of those, 63 metabolites had at
least one significant between-time-point difference, while 12 were
unchanged across all time points.
RESULTS
Standard FBA Does Not Accurately
Recapitulate Fluxes Measured in vivo in
Adult Animals
In order to study the dynamics of metabolic remodeling
during aging on normal lived animals, we generated linked,
temporally resolved, transcriptomic, and metabolomic data from
two normal lived sterile strains, covering days 1–10 of adulthood
(Figure 1A). C. elegans is a hermaphrodite species that produces
progeny through self-fertilization, which can contaminate the
aging parental samples. To avoid this confounding factor,
we used two conditionally sterile strains, gon-2(q388)ts; gem-
1(bc364) (GEM, hereafter), and fem-3(q20)ts (FEM, hereafter).
The gon-2 gene encodes a cation channel required for division
of postembryonic gonadal precursor cells (Sun and Lambie,
1997). At restrictive temperature, the gon-2(q388)ts mutation is
enhanced by mutation of the solute carrier gem-1 (Kemp et al.,
2009) but remains incompletely penetrant, resulting in delayed
and degenerate gonadogenesis. Thus, GEM animals possess a
degenerate gonad that by D4 might contain both sperm and
oocytes, and, in a small number of cases, embryos. The fem-
3 gene encodes a novel sex-determination gene and the gain-
of-function fem-3(q20)ts mutation causes temperature sensitive
masculinization of the germline (Barton et al., 1987). Thus, FEM
animals possess a normal hermaphrodite somatic gonad that
produces no oocytes but excess sperm and are 100% sterile.
Survival analysis confirmed that these strains displayWT lifespan
(Figure S2). During sample collection, each biological replicate
was partitioned so that both metabolomics and transcriptomics
data were produced from the same batch of worms.
Transcriptomics data can be used in combination with whole
genome models for the computational prediction of fluxes
(intracellular turnover rates) for metabolic reactions using FBA
and this approach has been previously used to predict fluxes in
normal and perturbed aging in worms (Gebauer et al., 2016). Two
assumptions are key to FBA. The first is that the modeled system
has reached a steady state (i.e., metabolite levels are no longer
changing), and the second is that the system has been optimized
through evolution to achieve some goal, usually considered to be
biomass production. The second assumption can be called into
question for aging animals, because they often live well beyond
the cessation of both growth and reproduction. For FBA to be
useful, it has to provide mechanistic insights into metabolism
and the accuracy of the predictions can be benchmarked against
many features including gene essentiality (Opdam et al., 2017)
and recapitulation of metabolic states when a certain reaction has
been removed (Gebauer et al., 2016).
We performed standard FBA (Supplementary Table 1) using
transcriptomics data obtained from FEM animals using the
whole-genome model of C. elegans metabolism, as described
in the Methods. As objective function, we maximized biomass
production (growth). We first performed flux-based pathway
analysis to detect pathways that were significantly changed in
day 10 compared to day 5 FEM animals (Figure S3C and
Supplementary Table 2). We found that the most enriched
Frontiers in Molecular Biosciences | www.frontiersin.org 5 February 2019 | Volume 6 | Article 2
Hastings et al. Metabolic Modeling During C. elegans Aging
FIGURE 1 | Experimental schematic. (A) Our experimental design included two sterile strains with differing gonadal composition sampled from early D1 of adulthood
(41 h post-L1-feeding, which coincides with the very end of the L4 to adult molt) to D10 of adulthood (257 h post-L1-feeding). For days 1 through 4, triplicate samples
were obtained. For days 5 and 10, duplicate samples were obtained. L1–L4 correspond to larval stages 1–4, L1 diapause is induced by hatching eggs in the absence
of food. (B) Schematic of the workflow of this article. (C) Diagram representing the methodologies used for FBA. Standard FBA uses only biomass production as an
objective function, while our approach combines the standard objective function with metabolomics data.
include fluxes through pathways that are expected to change with
age such as purine and pyrimidine and amino acid metabolism,
oxidative phosphorylation, glutathionemetabolism, and the TCA
cycle. Similar predictions were reached in previous studies where
FBA was applied to aging networks (Gebauer et al., 2016),
indicating that standard FBA can recapitulate overall metabolic
functionality.
However, the best method to ascertain FBA performance
is to compare predicted fluxes with in vivo measured fluxes.
Here, we took advantage of a previous study where mass
spectrometry was used to quantify fluxes using the relationship
between a labeled precursor (glucose, provided in the food)
and several products of the TCA cycle (Schrier Vergano et al.,
2014). The TCA cycle is composed of a series of enzymatic
reactions that include the core of aerobic respiration in the
mitochondria (a diagram in Figure S3A). The previousmetabolic
flux profiling directly measured fluxes through the TCA cycle in
wild type worms as well as inmutants for isocitrate dehydrogenase
(idh-1), the enzyme that produces alpha-ketoglutarate from
isocitrate (Figure S3A, reaction 3) (Schrier Vergano et al.,
2014). In the absence of this upstream enzyme, significant
changes in fluxes were identified that led to the accumulation
of lactate, fumarate, succinate, malate and in the depletion of
glutamate, and aspartate. We reasoned that if FBA was properly
recapitulating fluxes, then an in-silico removal of idh-1 enzyme
should render fluxes that are similar to those directly measured
in vivo. As a first approximation, we thus determined if standard
FBA could recapitulate the fluxes observed in vivo in idh-1
KO animals, when performing in silico knock out of idh-1
and idh-2 in young adult FEM animals. We observed that, as
expected, the loss of IDH activity eliminated fluxes through the
reaction it catalyzes (making alpha-ketoglutarate from isocitrate)
(Supplementary Table 3 and Figure S3B). In addition, in silico
lack of alpha-ketoglutarate concurred to some extent with in vivo
metabolic flux experiments, causing a reduction in the fluxes
that lead to glutamate production, and an increase in citrate
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FIGURE 2 | Characteristics of between-sample variability compared between metabolomics and transcriptomics datasets. (A,B) metabolomics (A), and
transcriptomics (B), show density plots of the distributions of pairwise sample-to-sample distances as grouped by samples that were replicates (black line), or shared
their age (but not strain) (red line and shaded area), or shared their strain (but not age) (blue line and shaded area). The density distribution being shifted toward the left
in these plots means that the samples were more similar (had a lower distance). These plots show that for the metabolomics dataset (A), samples with the same age
but different strains were closer than those with the same strain but different ages, while the opposite is true for the transcriptomics (B). This plot also illustrates that
there is greater technical variance in the metabolomics dataset than for the transcriptomics. (C,D) we conducted Principal Components Analysis (PCA) across the two
datasets [(C), metabolomics; (D) transcriptomics]. We visualized the samples projected onto the space of the first two principal components. Samples are colored by
strain–yellow for GEM, green for FEM. (E,F) the same principal components as in (C) and (D) are shown colored by age. [(E) metabolomics; (F) transcriptomics].
production. However, many of the altered fluxes measured in
vivo (Figure S3A), including those leading to accumulation of
succinate and malate, were not accurately reproduced by the in
silico knock out (Figure S3B).
Because in vivo fluxes were measured in wild type (N2)
young adult animals lacking isocitrate dehydrogenase activity, and
the in silico experiment was performed using a transcriptome
obtained from FEM young adult animals, one possibility is
that the unmatched genetic backgrounds explain the differential
fluxes. We think this is unlikely to be the main reason for the
discrepancy, because the Pearson correlation of gene expression
values between wild type and FEM animals at day 1 of adulthood
is close to 98%, and samples only begin to diverge more
significantly after day 2 of adulthood (data not shown). Although
it remains a possibility, this in silico experiment suggests that
although standard FBA can correctly predict global fluxes in
aging animals, when looking at the results at a finer scale, the
predictions may not be accurate. One likely scenario is that
an objective function geared only toward biomass production
may not appropriately reflect the biology of post-mitotic somatic
cells in adult aging animals, and that new objective functions
are required to study metabolism during aging. To obtain
a more accurate objective function, we enhanced our FBA
pipeline by integrating a metabolomics dataset into the objective
function together with the biomass production (Figures 1B,C).
As described below in the “Case study” section, the new objective
function was further validated entirely within the FEM genetic
background.
Different Sources of Variance for
Metabolome and Transcriptome in Linked
Samples
Quantification of metabolites is key for our understanding
of metabolism during aging. Metabolites are the downstream
product of the combined effect of transcriptional, post-
transcriptional, and post-translational events, together with
the influence of the environment, and therefore give a more
immediate picture of the metabolic and physiological state, that
may or may not correlate with corresponding transcripts. To
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determine how metabolomics data compares to transcriptomics,
we calculated sample-to-sample distances for both datasets
(Figure 2). As shown by the density plots, variability is affected
by age and by genotype. However, the effect of age was greater
than the effect of strain in the metabolomics dataset (Figure 2A)
whereas, variance was more striking by genotype rather than age
in the transcriptomics dataset (Figure 2B).
When using Principal Components Analysis (PCA;
Figures 2C–F) to look at the main determinants of variability
in the dataset, it is apparent that in the metabolomics data
(Figure 2E), the aging process is the major contributor to
variability between the samples, since the first principal
component, accounting for the majority of variability largely
aligns with age. On the other hand, the transcriptomics displays
a large division across both PC1 and PC2 by strain, although
age still accounts for a large proportion of the variability
(Figure 2F). This difference in drivers for the between-sample
variability cannot be due to batch differences in the underlying
sample material because the transcriptomic and metabolomic
samples were linked. We explore potential explanations for these
observations in the Discussion section. Figure S4 shows the
sample-to-sample correlation matrices for all samples in the
metabolomics (Figure S4A) and transcriptomics (Figure S4B)
datasets.
Age-Associated Metabolites Are Enriched
for Those Known to Promote Longevity
We used PLS-DA to reveal the metabolites that are significantly
associated with the age of the sample (statistical details in
Supplementary Methods, Figure S5). This gave 44 metabolites
presenting a significant change over the course of aging
(Supplementary Table 5). Note that PLS-DA is a linear
regression-based method, thus non-linear effects with respect to
age will be overlooked. To determine whether those metabolites
are likely to influence the aging process, we determined if these
were present in a database for metabolites known to influence
longevity (longevity modulators, determined from DrugAge
as described in the Methods). Twenty of our 44 age-associated
metabolites were known for their effect on longevity, more than
would be expected by chance since only 34 of all 105 measured
metabolites were in the database (Fisher’s exact test for over-
representation gives p = 0.013). Using a comprehensive search
of the literature we found 6 additional metabolites amongst our
age-associated metabolites that act as longevity modulators when
supplemented (Supplementary Table 5). To determine which
pathways were most enriched for age-associated metabolites, we
performed pathway enrichment analysis (Figure 3). The results
show that there is a correlation between metabolites that are
age-associated in our dataset and longevity modulators in the
DrugAge dataset.
The age-associated metabolites cluster into two main groups:
those that increase with age, and those that decrease with age,
as shown in the clustered heatmap (Figure 4). Overall the data
indicates that there is a clear shift for many metabolites. Two
patterns are readily evident. Some metabolites drift with age (a
gradually change for linoleic acid, hypoxanthine, and malate)
whereas, others show abrupt shifts at specific time points during
early or late aging. For example, the levels of several amino acids
drop at day 1 of aging (between 41 and 49 h), and then again
sometime after day 5 (137 h).
Our study generally agrees with other studies (Copes et al.,
2015; Gao et al., 2017a; Wan et al., 2017) and a cross-
comparison can be found in in Supplementary Table 6. The
first cluster (cluster 1 in Figure 4) of metabolites decreasing
over time contains most measured amino acids (including
serine, threonine, leucine, lysine, glutamate/glutamic acid,
methionine, tryptophan, and arginine) and some byproducts
of amino acid metabolism (homoserine, cystathionine) as
well as nucleotides (guanosine, cytidine, uridine, GMP).
The second cluster (cluster 2 in Figure 4) of metabolites
increasing with time contains degradation products of both
nucleotides (hypoxanthine, xanthosine, and allantoin) and amino
acid metabolism (betaine, carnitine, leucic acid, pentothenate,
kynurenic acid, and xanthurenic acid), confirming a well-
documented imbalance in amino acid and nucleotidemetabolism
with age (Copes et al., 2015; Gao et al., 2017a; Wan et al.,
2017). The age-related change in amino acids has been proposed
to be driven by the ratio of hydrophilic/hydrophobic surfaces
that accompanies cell volume changes related to growth, and
not by either age (Copes et al., 2015) or genotype (Gao et al.,
2017a). As shown in Figure S6, there is a significant change
in the worm’s size from days 1–5, but body size remains
stable thereafter. Therefore, when comparing days 5 and 10,
something other than changes in cell size must underlie amino
acid depletion in old animals. The large drop in these metabolites
may cause them to become metabolically limiting as previous
studies have shown that supplementation of specific amino acids
and nucleotides can extend lifespan (Copes et al., 2015; Edwards
et al., 2015).
We report here, for the first time, that there is accumulation
of polyamines with age, namely, putrescine, N-acetylputrescine,
and cadaverine. These metabolites display a sharp increase at
day 10 (Figure 4) while an intermediary, agmatine, decreases
significantly with age. Polyamines are low molecular weight
aliphatic polycations, derived from amino acids, ubiquitous
across species, and with many cellular functions. Putrescine is
metabolized from arginine via either agmatine or ornithine and
gives rise to spermidine, the precursor of spermine (Figure S7A),
while cadaverine is the product of lysine decarboxylation
(McCann, 1982). To check whether the observed metabolite
changes aligned with changes in the corresponding metabolic
gene pathways, we integrated the two datasets using the
R library Pathview. As shown in Figure S7A, displaying
the overlay of transcriptomics and metabolomics using
Pathview, there is a significant age-dependent upregulation
in the levels of spermidine synthase (see EC 2.5.1.16 in
Figure S7A) in day 10 animals. This enzyme catalyzes the
transfer of a polyamine group from S-adenosylmethioninamine
to putrescine in the biosynthesis of spermidine, possibly
reflecting an increased usage of spermidine with age. The
polyamine spermidine has been associated with lifespan
extension by activating autophagy across species (Eisenberg
et al., 2009; Minois, 2014) and the implications of an increase
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FIGURE 3 | Bubble plot of pathway enrichment for age-associated metabolites. The pathways that are most red are the ones that have the most age-associated
metabolites, while the ones that are the most blue have the least. Circle radius represents the number of measured metabolites in the pathway. The x axis shows the
proportion of metabolites in the pathway that are changing intensity with age in our study, and the y axis shows the proportion of metabolites in the pathway that are
known to modulate longevity in the Drug Age database, illustrating that these measures are broadly correlated.
FIGURE 4 | Clustered heat map showing metabolite levels over time. The heat map shows row (metabolite) Z-scores, i.e., deviations from the average across time
points for each metabolite. Each metabolite range is scaled so that it has mean of zero and standard deviation of one. Each time point represents the average for
biological replicates. The samples are ordered first by strain (green is FEM, yellow is GEM), then by age. The row sidebar illustrates whether the metabolites have been
determined to be increasing or decreasing with age (red for increasing, blue for decreasing).
in polyamines with age are further explored in the Discussion
section.
As shown in Figure 4, many metabolites that are involved
in central carbon metabolism, particularly the TCA cycle, were
significantly changed with age, e.g., lactate and oxaloacetate.
An imbalance in the TCA cycle in 10-day old animals has
been previously described (Wan et al., 2017) and we observed
in our metabolomics data a consistent change in both FEM
and GEM with age, indicating that changes were independent
of the genotype. Overall, there was a striking change in TCA
metabolites in 10-day adults compared to day 5 or younger
worms and some of the changes observed were in line with
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FIGURE 5 | Objective function for endo-metabolomics inclusion. (A) A
schematic of the objective function for endo-metabolomics inclusion into FBA
is shown. Endo-metabolomics metabolite levels are obtained for each time
point. Between each pair of consecutive time points (illustrated as t1 and t2), a
statistical test reveals for each metabolite whether the level has increased (UP)
or decreased (DOWN) between those two points. The integration of this
information with the model uses the transcriptomics constraints from the
second time point (t2) as an imation for the time frame (t1–t2) and adds a new
system boundary as an additional objective function to reflect the changes in
metabolite levels either as inputs or outputs to the system. (B) The relationship
between metabolite level changes between consecutive time points and the
assumed flux over the time frame is illustrated. An example of two consecutive
level changes are shown for the hypothetical metabolite M which has a level
decrease between time points t1 and t2, and a level increase between time
points t2 and t3. During the time frame f1 for the duration between time points
t1 and t2, demand exceeds supply. During the time frame f2 for the duration
between time points t2 and t3, supply exceeds demands.
changes in idh-1 mutants (Figure S8). These metabolic changes
may reflect the widespread fragmentation of mitochondria that
begin at around this stage (Yasuda et al., 2006; Regmi et al.,
2014). Pathview analysis indicated that most detected transcripts
for TCA enzymes show decreased levels with age (Figure S7B)
with the exception of citrate synthase, which catalyzes the first
step of the TCA cycle condensing acetyl-CoA and oxaloacetate
to form citrate. This suggests that citrate accumulates with
age, although we did not directly measure it. Pathview
analysis also revealed that for succinate there was a mismatch
between the transcripts of the enzymes required for succinate
production and consumption, and the levels of the metabolite,
perhaps reflecting post-transcriptional alterations to the key
enzymes.
Flux Balance Analysis Performed With
Metabolomics-Integrated Objective
Function Reveals Dynamic Metabolic Flux
Changes During Aging
Standard FBA constrained by biomass production was unable
to recapitulate measured in vivo fluxes through the TCA
cycle (Figure S3B). To obtain a more accurate objective
function, we integrated information from the metabolomics
dataset. We reasoned that a statistically significant change in
the concentration of a metabolite between two consecutive
time points could only happen if the metabolite was either
net-produced or net-consumed between those time points.
Therefore, we added a system boundary for the production
or consumption of the relevantly changed metabolites as
an additional objective function at each time point and
simultaneously maximized biomass as well as production
or consumption of the relevant metabolites (Figure 5). We
called this method Metab_FBA (Supplementary Table 7)
using the combined objective function, and referred to the
method where only the conventional objective function was
used as Standard FBA (Supplementary Table 1). The new
metabolomics-integrated objective function provides the model
with a guideline for production and consumption of metabolites,
without supervising the possible solutions reached by the model,
therefore the predictive value of the re-optimized objective
function is 2-fold. Firstly, it provides quantitative information
about the most affected fluxes when producing or consuming
a measured metabolite, and secondly, it provides predicted
fluxes for all reactions that produce or consume unmeasured
metabolites.
The addition of metabolomics data to the objective function
does not dramatically change the enrichment of metabolic
pathways represented, although there are differences in rank
(Figure S3D and Supplementary Table 2). Previous approaches
to incorporate -omics data with FBA have been validated by
confirming that the overall variability of flux predictions -
the sum of the range of flux variabilities for each reaction–is
reduced (e.g., Kleessen et al., 2015). A large variability usually
represents a large solution space that is reduced by applied
constraints. We have similarly ascertained the variability range
for our flux predictions (Figure S9A) and confirm that the
inclusion of the transcriptomics data as constraints does reduce
the flux variability ranges, in line with what has been previously
reported, but inclusion of metabolomics data alongside biomass
as the objective function on top of the transcriptomics-derived
constraints does not appreciably reduce the flux variability
further. This is to be expected, since the method of integration
-as an additional component of the objective function- does not
aim to constrain the solution space, but rather helps to guide
the selection of an optimal solution within the solution space to
be more physiologically accurate. We furthermore compared our
approach to an approach which incorporated the metabolomics
data as constraints on the production or consumption of
metabolites rather than as additional information in the objective
function. We observed that incorporation as constraints, in
some cases, narrows the solution space too much, due to
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FIGURE 6 | Dynamic changes in pathway fluxes over time. (A–C) Dynamic Changes in Fluxes as a function of age, grouped by pathways. These plots show the
magnitude of summed flux values at different timeframes per strain and pathway for the TCA cycle (A), glycolysis (B), and oxidative phosphorylation (C). As before,
the fluxes are plotted against the timepoint that provided the transcriptomics data. Example the flux at 137 h is the flux computed for the timeframe between 117 and
137 h. (D) Heat Map of the Fluxes catalyzed by reactions related to the TCA cycle in FEM animals at day 1 (41 and 49 h), day 2 (65 and 72 h), day 3 (89 h), day 4
(117 h), day 5 (137 h), and day 10 (257 h). Note that time point 97 is not shown as there were no significant metabolic differences at that time point. Greater flux values
are indicated in red, lower in blue. As the underlying model represents bidirectional reactions, in some cases, fluxes in the reverse direction are encoded by negative
flux values. The heat map here shows the absolute magnitude of the fluxes; the direction of the fluxes and the reactions are given in Supplementary Tables 1, 7. All
reactions and metabolites used by the WormJam model are provided in Supplementary Tables 12, 13.
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incompatible metabolomics and transcriptomics constraints,
leading to the inability of the model to generate biomass under
that setup (Figure S9B). This highlights that incorporation of
the metabolomics information as objective function gives the
maximal flexibility to the system to find the best possible
solution maximizing congruence between transcriptomics and
metabolomics datasets.
Case Study: Using Two Objective
Functions to Predict Metabolic Fluxes
Through the TCA Cycle in Aging Animals
To test the performance of the two FBA variants, we focused
on the TCA cycle because it is conserved between C. elegans
and mammals, and well-annotated in C. elegans metabolic
reconstruction models. Metab_FBA provides different fluxes
than standard FBA in several aspects of central metabolism
(Figures 6A–C). First it predicts a peak in glycolysis during day
1 and in TCA cycle during day 2, which is also evident in
the heatmap of TCA cycle fluxes (Figure 6D). Within the same
time frame, oxidative phosphorylation shows a compensatory
decrease, which is not evident using standard FBA (Figure 6C).
Interestingly, in FEM animals but not GEM,Metab_FBA predicts
a sharp decline in TCA cycle total flux between days 4 and 5
(subsequently referred to as time frame “days 4-5”) and between
days 5 and 10 (subsequently referred to as time frame “days
5-10”), and this sharp decrease in metabolic function is not
predicted by standard FBA.
As noted earlier, we noticed that GEM mutants were
incompletely penetrant, thus some animals developed a
rudimentary gonad and were able to produce progeny. To
eliminate potential confounding effects of the small number of
progenies, we focused our analysis primarily on FEM animals,
which are 100% sterile. In line with our previous observation
that Standard FBA does not accurately recapitulate in vivo
measured fluxes (Figure S3B), we observed that Standard FBA
predicted that most fluxes across the TCA cycle remained
unchanged between days 5 and 10 (Figure 7A). However, we
know this cannot be correct as we had demonstrated that
many TCA-related metabolites change with age (Figure 4
and Figure S8). When we included our metabolomics data as
part of the objective function, the model predicted a general
decrease in fluxes through the TCA cycle in agreement with the
measured changes in metabolites (Supplementary Table 10 and
Figure S8). These improved predictions should thus provide
more confident grounds for hypotheses surrounding metabolites
that were not measured.
We looked into oxaloacetate in more detail because fluxes
through this metabolite were predicted to be the most
depressed with age. Metab_FBA predicted that fluxes through
the reaction MDH_m, which represents the conversion of malate
to oxaloacetate by malate dehydrogenase in the mitochondria,
was dramatically reduced from days 4–5 and days 5–10 in
FEM (reaction 8 in Figures 7B,D). At the same time, CS_m,
which represents the conversion of oxaloacetate to citrate in
the mitochondria, was also substantially reduced (reaction 1
in Figures 7B,D). To get a measure for the net production of
oxaloacetate in the mitochondria, we calculated the difference
between the sums of all mitochondrial oxaloacetate catabolic
and anabolic reactions for each timeframe. This returned
values of 7 on days 4–5 and 4 on days 5–10 (a 43%
reduction) (Supplementary Table 10). Thus, the Metab_FBA
model predicts that net production of oxaloacetate in the
mitochondria drops after day 4. Although we did not provide
specific instructions as to what solution to find, in this
model the objective function contained the information that
oxaloacetate levels dropped between these two timeframes. One
possibility is that this predicted flux is based solely on the
direct measurements of oxaloacetate, and if so, this may indicate
that the inclusion of this information was disproportionately
biasing the data. To rule this possibility out, we re-executed
Metab_FBA without measurements for oxaloacetate, and termed
this variant, Metab_FBA_no_OAA (Supplementary Table 8).
In this model (Figures 7C,D), we found that fluxes through
MHD_m (reaction 1 in Figure 7C) remained the most depressed
from days 4–5 to days 5–10 and net production of oxaloacetate
dropped by 25% (from an 8 on days 4–5 to 6 on days 5–
10). This indicated that even without additional information
for this specific metabolite, the model still correctly predicted a
substantial drop in oxaloacetate production.
The striking difference in the fluxes within the TCA cycle
affecting oxaloacetate between days 4–5 and 5–10 suggested that
oxaloacetate may be a limiting metabolite when animals reach
middle age. The accuracy of a model is generally tested by its
ability to predict gene essentiality or metabolic functionalities
(Opdam et al., 2017). In the case of aging animals, survival is a
more appropriate phenotype to use for benchmarking purposes.
We reasoned that if a metabolite becomes limiting with age, then
supplementation of the metabolite in the diet should increase
survival, or in other words, extend lifespan. Consistent with
this prediction, while supplementation of most TCA metabolites
either does not affect lifespan, or has only a small effect (Edwards
et al., 2013, 2015), oxaloacetate extends lifespan by 25% and it
depends on both AMP-activated protein kinase (AMPK) and
insulin signaling (Williams et al., 2009). This illustrates how the
new objective function in Metab_FBA outperforms a standard
objective function based on growth by providing more accurate
predictions about a key metabolite. The fact that oxaloacetate
supplementation has been shown to have such an important
impact on lifespan also indicates that dysfunctional mitochondria
is not just a co-morbidity related to age deterioration, but rather
that it is one of the drivers of the aging process.
The TCA cycle is a source of energy but it can also produce
and consume amino acids such as glutamate and aspartate
(reactions 10 and 11 in Figure S3A). We therefore hypothesized
that the age-related disruption of the TCA cycle could account
for alterations in these amino acids with age. Because we did not
directly measure aspartate, we focused our analysis on glutamate,
which significantly decreased with age (Figure 4). The fluxes
through reactions that connect glutamate to the TCA cycle are
listed in Supplementary Table 11. Fluxes predicted by standard
FBA are either inactive or unchanged from days 5 and 10 in FEM
animals (Figure 8), and therefore conventional FBA modeling
does not account for our in vivo measurements of glutamate.
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FIGURE 7 | Representation of metabolic fluxes through the TCA cycle in FEM animals using three different objective functions. (A–C) TCA cycle reactions represented
with the Escher tool (King et al., 2015) as a comparison between FEM data for the timeframes at days 4–5 (117–137 h) and days 5–10 (137–257 h) for FBA objective
function variants Standard_FBA (A), Metab_FBA (B), and Metab_FBA_no_OAA (C), which does not include (A) or includes information regarding all quantified
metabolites (B) or all except oxaloacetate (C) in their respective objective functions. The maps have been colored in Inkscape and colors represent the difference in
the fluxes between the two time points, where red is increased and blue is decreased. The weight of the arrows has been adjusted to indicate the magnitude of the
change. (D) The differences between the two time frames are illustrated per reaction for each of the three FBA variants. The reaction identifiers from the WormJam
model shown in (D) are illustrated in Figure 2A as follows: R_RMC0001: isocitrate hydro-lyase (reaction 1); R_ACONITATEHYDR_RXN_m: aconitase - isocitrate
hydrolase (reaction 1a); RMC0001: Cytosolic isocitrate hydrolase (reaction 2) ; AKGDH_m: Mitochondrial 2-oxoglutarate dehydrogenase (reaction 3); RXN909_8_m:
Mitochondrial succinate dehydrogenase (reaction 4); RM02164: Succinate:ubiqui oxidoreductase (reaction 5), FUM_m: Mitochondrial fumarate hydratase (reaction 6),
MDH_m: Mitochondrial malate dehydrogenase (reaction 7), CITL_m: Citrate lyase (reaction 8), ISOCITDEH_RXN_m: Mitochondrial isocitrate dehydrogenase (reaction
9). The reactions represented in TCA diagrams have been labeled with appropriate numbers in the Y axis. All other reactions and metabolite identifiers are listed in
Supplementary Table 10.
When using the modified objective function, Metab_FBA
predicts that several fluxes that connect TCA metabolites with
glutamate are substantially altered (Figure 8). First, although
fluxes that lead to glutamate production in the cytosol remain
unchanged (Figure 8A), all fluxes inside the mitochondria that
contribute to production or consumption of glutamate were
decreased (Figures 8B,C). To illustrate, the sum of total fluxes
inside the mitochondria dropped from 3.4 to 1.8 according to
Metab_FBA, whereas Standard FBA predicted a reduction from
0.47 to 0.33 from days 5 to 10 (Supplementary Table 11 and
Figure 8D). To specifically rule out that the optimized objective
function is not biasing the results by forcing fluxes through
glutamate, we asked if the model arrives at a similar solution in
the absence of direct prior information about glutamate. In this
in silico experiment, fluxes were re-calculated using a modified
objective function that included all measured metabolites except
for glutamate (Metab_FBA_no_GLU, Supplementary Table 9).
Eliminating this information, however, did not significantly
change the overall results and predicted that the net fluxes
through the mitochondria decrease from 3.4 to 2.7, which is
a smaller reduction than Metab_FBA, but still much higher
than standard FBA (Supplementary Table 11 and Figure 8),
indicating that the model’s predictive capacity is robust. Given
that fluxes leading to catabolism of glutamate are predicted to
sharply decrease with age, a plausible hypothesis is that depletion
of glutamate in old animals is caused by a failure of the TCA
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FIGURE 8 | Predicted exchange fluxes for glutamate inside the mitochondria and cytosol by three different FBA models. All comparisons refer to reactions that
connect glutamate to the TCA cycle in days 4–5 or days 5–10 FEM samples using three different FBA models: Metab_FBA, which includes information for all
measured metabolites; Metab_FBA_no_GLU, which includes information for all measured metabolites except for glutamate; and Standard_FBA, which does not
include metabolite measurement information. (A) Difference between cytosolic consumption and production. (B) Fluxes that produce glutamate within the
mitochondria (C) Fluxes that consume glutamate inside the mitochondria (D) Difference between mitochondrial production and consumption per day per model. All
data is available in Supplementary Table 11.
cycle to replenish glutamate. This model is likely to be correct for
two reasons. First, as pointed out earlier, the TCA cycle appears
to be dysfunctional in old animals. Secondly, this prediction is
consistent with fluxes measured in vivo using labeled carbon
sources. Schrier Vergano et al. (2014) found that upon knock-
down of components of ETC complexes I to IV as well as in
TCA-cycle defective idh-1 mutants, glutamate become depleted
in worms (Figure S8), connecting a malfunctioning TCA cycle
with cellular AAC content.
DISCUSSION
Potential Drivers of the Differences in
Sample Variability Between Metabolomics
and Transcriptomics Data
One possible reason for the observed discrepancy in sample
variability between transcriptomics andmetabolomics (Figure 2)
is that the targeted metabolomics assay we used covers a
small subset of metabolites of central importance, which are
therefore likely to be highly conserved across strains under
similar environmental conditions. Conversely, transcriptomics
samples thousands of transcripts and is therefore likely to
be much more sensitive to strain-to-strain differences. We
might thus hypothesize that the metabolomics data should
show more between-strain differences if we had used an
untargeted metabolomics assay in which the dataset comprised
all metabolites. An alternative explanation is that the most
important source of metabolites in worms is the intestine,
whereas the germline may be depleted of metabolites but
enriched in transcripts. Thus, the different germline composition
of GEMs and FEMs may explain the divergent trajectories.
However, we obtained similar results when we excluded genes
shown to be enriched in the germline (data not shown),
making this less likely. Finally, there are several layers of
regulation upstream of metabolites and the misalignment
between metabolomics, and transcriptomics may indicate an
important layer of post-transcriptional control of metabolism.
The Middle Age Switch to Produce
Polyamines and Ketone Bodies May Be the
Consequence of Reduced Food Intake
With Age
We report for the first time a large increase in polyamines which
happens after day 5 of adulthood. The levels of the metabolite
spermidine were highly variable in our dataset and thus we could
not detect a significant change in levels across time. However,
as shown in Figure S7, spermidine synthase, which catalyzes
the biosynthesis of spermidine, is upregulated. Supplementation
of putrescine and agmatine increases lifespan in worms by
10–20% (Edwards et al., 2015) whilst the role of cadaverine
remains unexplored. Spermidine has been associated with
lifespan extension by activating autophagy (Eisenberg et al., 2009;
Minois, 2014). Autophagy is a well-described fasting response
that recycles cellular components to restore the energy balance.
It is interesting to note that the levels of 3-hydroxybutyric acid
(3HBA) behave similarly to the polyamines. 3HBA is metabolized
from ketogenic amino acids, and/or lipids and it is a component
of ketone bodies, which supply energy during periods of fasting
(Veech et al., 2017). This suggests that 10 day old animals
have reduced food intake, perhaps as a consequence of well-
described loss of pharyngeal pumping activity with age (Russell
et al., 2017). At the same time, we observe significantly increased
levels of spermidine precursors, thus, polyamine synthesis may
be enhanced in day 10 animals so as to stimulate autophagy
when nutrient availability from food intake becomes limiting.
Autophagy can also mediate the conversion of intestinal biomass
into yolk, causing documented early aging pathologies (Ezcurra
et al., 2018). Therefore, autophagy can have positive and negative
consequences for longevity. The seemingly contradictory nature
of these two observations might be further clarified by gaining a
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deeper understanding of the underlying molecular mechanisms
that trigger autophagy and the physiological contexts where it is
used. A plausible scenario is that the increase in polyamines that
may result from reduced food intake at day 10, may promote a
switch in autophagy away from lipoprotein pool production into
a survival strategy aimed at coping with malnutrition, which may
be beneficial for survival.
Limitations of Metab_FBA and Outlook
We have presented the first study of aging in normal-lived C.
elegans to use FBA together with a time-resolved transcriptomics
and metabolomics dataset. While we used existing strategies for
the transcriptomics integration, the strategy we used to integrate
the time-resolved metabolomics data with the objective function
of the FBA is novel, and based on our case study of the TCA
metabolism we have found that it yields results that are closer to
the physiology than what is predicted with transcriptomics data
alone.
An important limitation of our method is that incorporation
of the metabolomics differences in the objective function
without quantitative constraints may result in the model having
too much freedom to optimize production or consumption
of those specific metabolites and as a result may generate
excessive fluxes, although in the right direction. For example,
in Figures 6A,B, the model predicts peaks in fluxes through
carbohydrate metabolism at 49 h and through the TCA cycle
at 73 h. The use of neighboring time points rather than overall
trends in metabolomics measurements to calculate differences
for incorporation into the model may also lead to an increase
in noise (Type 2 errors). To mitigate these problems, we might
calculate a linear rate of change for metabolite level changes
across a number of time points (as is done, for example, in
Bordbar et al., 2017) and use those per-metabolite linear rates of
change as constraints on the relevant reactions that are added to
the objective function. We plan to test this combined approach
in future work. Moreover, the set of metabolites available for the
study was limited and may have introduced bias to the results.
In future a more comprehensive, untargeted metabolomics assay
might be used to obtain a whole-metabolome view on systemic
changes due to aging.
Another limitation of our study is the incomplete state of
annotation of the model of C. elegans metabolism. While the
WormJam model represents the consensus of the knowledge
represented across all the available published models, it is a work
in progress and there are known problems which require further
manual curation to resolve (Witting et al., 2018). For example,
the annotation of worm-specific metabolites is poor, as is the
annotation of pathways involving fatty acids and lipids.
We anticipate that other approaches to changing the objective
function will also enhance the use of FBA for the study
of aging in C. elegans, for example, the addition of in vivo
measured oxygen consumption and total ATP production data
at matching timepoints. We demonstrate that our method is
able to accurately predict changes in metabolite levels for which
no metabolite information is provided, thus with the addition
of relatively easily obtainable data (e.g., metabolites for which
good standards exist), our model may be used to predict
system level metabolic shifts or changes in metabolites that
are more difficult to quantify (i.e., those without appropriate
standards).
Our Data Reveals a Dramatic Drop in
Mitochondrial Function With Age and our
FBA Analysis Reveals Interconnected
Consequences With Other Metabolic
Functions
Transcriptomics data indicates that the function of the TCA
cycle is gradually reduced and there is a corresponding gradual
decrease of mitochondrial oxygen consumption with age (Brys
et al., 2010). The production of ATP in older animals has
been determined to be 20% that of young adults (Braeckman
et al., 2002). However, our metabolomics data shows that TCA
intermediates are changed dramatically sometime after day 5 of
adulthood (and after day 7, as observed in Gao et al., 2017a). It
is not known, however, what triggers the loss of functionality of
the mitochondria in normal lived animals with age, but it can
be reversed by mutations in AMPK homolog aak-2, a master
regulator of energy homeostasis (Weir et al., 2017). In C. elegans,
mitochondrial fusion is necessary but not sufficient for longevity
assurance, suggesting that energy must become limiting with
age and that stable energy levels must be required to maintain
energy consuming processes such as protein folding homeostasis
(Chaudhari and Kipreos, 2018).
The mitochondrial free-radical theory of aging–which
proposed that free radicals released by mitochondria are the
drivers of aging–cannot be correct because removing radicals
does not extend lifespan (Honda et al., 2008). Recently, an
alternative idea has been proposed where free radicals cause
local damage to the mitochondria, causing a drop in energy
production (Chaudhari and Kipreos, 2018). Free reactive
oxygen species (ROS) can also have a healthy hormetic effect
on mitochondria (Ristow and Zarse, 2010) so for this theory
to be correct, ROS action has to be threshold dependent. One
potential explanation for our observations of the loss of TCA
cycle function is that such a threshold has been crossed after
day 7, precipitating the loss of mitochondrial function. In
support of this hypothesis, we also observed a drop in aconitate
levels, which is synthesized by aconitase. The activity of this
enzyme is sensitive to ROS because it undergoes oxidative
modification and inactivation during aging and in certain
oxidative stress related disorders (Lushchak et al., 2014).
Interestingly, we observed that aconitate levels drop earlier
than oxaloacetate levels, suggesting that ROS may precipitate
TCA cycle dysfunction. Another possible explanation for our
observations is that altered mitochondrial dynamics cause
local imbalances between the levels of substrates and products,
which could initiate aberrant feedback loops or reduce enzyme
efficiency. A completely different explanation is that by day
10 many of the described comorbid pathologies have already
reached their maximum levels (Ezcurra et al., 2018) pushing
the limits of the system into collapse. Because the collapse
of mitochondrial function is evident in the metabolomics
data and not in transcriptomics, a post-transcriptional switch
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may be required. The addition of proteomics data would
help to address this question, and is indicated for future
work.
Overall, we observe that the use of FBA with metabolomics as
part of the objective function provided accurate predictions with
regards to the most affected reactions of the TCA cycle with age.
Specifically, using the combined objective function accurately
predicted that oxaloacetate is the metabolite that becomes most
limiting with age, a prediction that matches the observation
that it is the single most effective TCA cycle intermediate
in extending lifespan upon supplementation (Williams et al.,
2009). Oxaloacetate supplementation elevates the levels of
NAD+ and restores redox balance, acting through sirtuins and
AMPK (Roth and Ingram, 2016). In mouse models of stroke,
oxaloacetate administration has been reported to reduce neural
damage and traumatic brain injury (Roth and Ingram, 2016).
Although the role of oxaloacetate as a healthspan modulator
requires more scrutiny, a product containing oxaloacetate is
already marketed for human consumption (www.benegene.
com). There are also NAD+ synthesis stimulation therapies
being marketed for human consumption (e.g., Basis by Elysium).
Our model also predicts that the TCA cycle can have an
impact on the fluxes of amino acids such as glutamate.
Other more extensive predictions that relate the TCA cycle
to lipid metabolism will be possible when the metabolic
reconstruction model becomes extensively annotated for these
pathways.
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